Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/PFIZER-INC-23365019/news/Roivant-and-Pfizer-Form-New-Vant-Company-Focused-on-Developing-TL1A-Drug-Candidate-for-Inflammatory-42453272/?utm_source=whatsapp&utm_medium=social&utm_campaign=share